default author photo

Fei Ye

Vanderbilt University - Department of Biostatistics

2301 Vanderbilt Place

Nashville, TN 37240

United States

SCHOLARLY PAPERS

2

DOWNLOADS

65

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

A Single-Cell Molecular Atlas of White Adipose Tissue Shows Differences in Myeloid and Lymphoid Cell Polarization in Type 2 Diabetes and HIV Infection

Number of pages: 73 Posted: 29 Apr 2022
Vanderbilt University - Division of Infectious Diseases, Vanderbilt University - Division of Allergy and Pulmonology, Vanderbilt University - Division of Infectious Diseases, Vanderbilt University - Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University - Tennessee Center for AIDS Research, Vanderbilt University - Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University - Department of Biostatistics, Vanderbilt University - Department of Biostatistics, Murdoch University - Institute for Immunology and Infectious Diseases, Murdoch University, Vanderbilt University - Division of Infectious Diseases, Vanderbilt University - Division of Infectious Diseases, Vanderbilt University - Division of Infectious Diseases, Vanderbilt University - Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University - Division of Infectious Diseases and Vanderbilt University - Division of Infectious Diseases
Downloads 35 (1,249,711)
Citation 1

Abstract:

Loading...

Human immunodeficiency virus, Type 2 diabetes mellitus, white adipose tissue, subcutaneous adipose tissue, Single-cell RNA sequencing, immune cells

2.

The Impact of Glucose Homeostasis on Immune Checkpoint Inhibitor Outcomes, Survival, and Immune Related Adverse Events

Number of pages: 11 Posted: 15 Jul 2025
affiliation not provided to SSRN, Vanderbilt University - Vanderbilt-Ingram Cancer Center, affiliation not provided to SSRN, Vanderbilt University - Department of Biostatistics and Vanderbilt University - Vanderbilt-Ingram Cancer Center
Downloads 30 (1,318,317)

Abstract:

Loading...

immune checkpoint inhibitors, immunotherapy, CTLA-4, PD-1, metastatic melanoma, patient outcome, treatment toxicity